Lantus (insulin glargine) has been a backbone basal insulin for people with type 1 and type 2 diabetes for years, and Sanofi's savings programs are genuinely generous compared to where insulin pricing used to sit. But "the Lantus savings card" isn't one single thing — it's two separate programs with different rules depending on your insurance status, plus a third option for patients who need it completely free. On top of that, the insulin glargine market itself shifted in a real way at the end of 2025 when a major biosimilar disappeared. This guide sorts out all of it: which program applies to you, what it actually costs, and what to do if your usual product is hard to find at the pharmacy.
1. What Is the Lantus Savings Card?
Sanofi runs two distinct savings programs for Lantus, and confusing them is the single most common mistake patients make when searching for "the Lantus savings card."
| Program | Who It's For | What You Pay |
|---|---|---|
| Lantus Copay Savings Card | Commercially insured patients | $35 or less per 30-day supply, up to 10 packs/fill |
| Insulins Valyou Savings Program | Uninsured, or insured patients paying cash | $35 per 30-day supply of one or combined Sanofi insulins |
Both programs exclude Medicare, Medicaid, VA, DOD, TRICARE, and similar government programs. Both are administered directly by Sanofi and require registration before your first discounted fill — see the official terms at lantus.com/sign-up-for-savings.
2. Big Update: Semglee Is Gone — What Replaces It
This is the development that's reshaped the entire insulin glargine landscape heading into the second half of 2026. Biocon discontinued Semglee — its vials and pens — on December 31, 2025. Semglee mattered because it was the first FDA-designated interchangeable biosimilar insulin, meaning a pharmacist could substitute it for Lantus automatically, the same way a generic gets swapped in without a new prescription.
What happened next: millions of patients who were stable on Semglee had to shift back to brand Lantus or another glargine product almost overnight. That demand shock is the main reason Sanofi has acknowledged intermittent supply pressure on the Lantus SoloStar pen specifically through 2026 — vials have generally stayed easier to find than pens.
The practical question for most patients is: what replaces Semglee's convenience? The answer is Rezvoglar, made by Eli Lilly. It's also FDA-designated interchangeable with Lantus, so in most cases a pharmacist can substitute it the same way Semglee worked, without going back to your prescriber first — though it's worth confirming with your specific pharmacist, since interchangeable status doesn't guarantee every pharmacy stocks it or that every state applies substitution rules identically.
- Rezvoglar (Lilly): interchangeable — can typically be substituted at the pharmacy like Semglee was.
- Basaglar (Lilly): a related follow-on insulin glargine, but not interchangeable — needs a new prescription from your doctor.
- Generic (unbranded) insulin glargine: available from several manufacturers, regional availability varies.
- Toujeo (Sanofi): also insulin glargine, but a different concentration (U-300 vs. Lantus's U-100) — not a unit-for-unit swap.
See our dedicated Lantus shortage guide for real-time availability tips and pharmacy-finding tools if you're currently struggling to fill a SoloStar pen prescription.
3. Is There a Lantus Coupon or Manufacturer Coupon?
Sanofi doesn't issue a traditional printable "coupon" for Lantus. When people search for a Lantus coupon or manufacturer coupon, they're describing the same benefit as the two programs above — they function like a coupon at checkout, but the terms depend on your insurance status rather than a flat discount code.
Bottom line: "Lantus coupon" almost always means either the Copay Savings Card or the Valyou Savings Program described in this guide. A free discount card like GoodRx or SingleCare is a separate, independent option that can sometimes match or beat Sanofi's own pricing — typically in the $35–$100 range per fill — but it can't be combined with Sanofi's programs on the same transaction. See our GoodRx vs. Inside Rx comparison for how these independent cards stack up generally.
4. Lantus Copay Card: For Commercially Insured Patients
If you have employer-sponsored or ACA marketplace insurance, the Copay Savings Card can bring your Lantus cost down to $35 or less for a 30-day supply, up to 10 packs per fill, with one fill allowed every 30 days.
- Federal Employees Health Benefits (FEHB) plans are treated as eligible — FEHB is not considered a government program for this specific offer.
- ACA Health Insurance Exchange plans are eligible too.
- Not valid if your prescription is billed to Medicare, Medicaid, VA, DOD, TRICARE, or a similar state pharmaceutical program.
Watch for copay accumulator programs. Some commercial plans apply Sanofi's contribution to your bill without counting it toward your deductible or annual out-of-pocket maximum. Ask your insurer directly whether your plan uses a copay accumulator or maximizer for brand-name drugs.
5. Lantus Savings Card Without Insurance (Valyou)
Uninsured patients — and insured patients who choose to pay cash instead of running Lantus through their benefit — use the Insulins Valyou Savings Program instead of the Copay Card. It caps the price at $35 per 30-day supply of any one or combination of Sanofi insulins.
The fine print that trips people up: to get the combined $35 cap, you must fill all of your Sanofi insulin prescriptions together, at the same time, each month. If you take only Lantus, this is simple. If you take Lantus plus another Sanofi insulin, filling them on different days can affect whether the combined cap applies.
Without any program, a 10 mL vial of Lantus typically runs somewhere between $80 and $360 depending on the pharmacy, following Sanofi's 78% list price reduction that took effect in 2024 — pen formats can run somewhat higher. The Valyou program brings either format down to $35 for a 30-day supply.
6. Free Lantus: Sanofi Patient Connection
For patients who can't manage even $35 a month, Sanofi Patient Connection can provide Lantus at no cost if you meet its eligibility rules:
- U.S. or U.S. territory resident, under the care of a licensed prescriber.
- No insurance coverage or access to Lantus through your existing plan.
- If you might qualify for Medicaid, you'll generally need to show documentation of a Medicaid denial first.
- Household income at or below 400% of the Federal Poverty Level.
Our Sanofi Patient Connection guide walks through the full application in detail, and our broader patient assistance program directory covers comparable programs from other manufacturers if you're managing more than one prescription.
7. Lantus Cost: List Price vs. Card vs. Alternatives
| Option | Typical Monthly Cost | Best For |
|---|---|---|
| Lantus, no assistance | ~$80–$360 (vial), often more for pens | Not recommended if any program applies |
| Lantus + Copay Card, commercial insurance | $35 or less | Commercially insured patients |
| Lantus + Valyou Program, uninsured | $35 | Uninsured or cash-pay patients |
| Free discount coupon (GoodRx/SingleCare) | ~$35–$100 | Comparison shopping against Sanofi's own terms |
| Sanofi Patient Connection | $0 | Uninsured patients at or below 400% FPL |
| Medicare Part D | $35 (IRA cap) | Medicare enrollees |
See our Medicare Part D insulin cap guide for how the Inflation Reduction Act's $35/month protection actually works at the pharmacy counter, and our Extra Help (LIS) guide if your income is limited and you're on Medicare.
8. Eligibility & Who Qualifies
Commercial Insurance
Copay Savings Card, $35 cap.
Uninsured / Cash-Pay
Valyou Program, $35 cap.
Medicare
Excluded — Part D's own $35 cap applies instead.
Medicaid
Excluded — state formulary rules apply instead.
9. Income Limits Compared
| Program | Income Limit | Insurance Requirement |
|---|---|---|
| Lantus Copay Savings Card | None | Commercial insurance required |
| Insulins Valyou Savings Program | None | Uninsured or paying cash |
| Sanofi Patient Connection | ≤400% of Federal Poverty Level | Uninsured or no access via existing plan |
| Medicare Extra Help (LIS) | Federal thresholds updated annually | Enrolled in Medicare Part D |
10. Covered Medications Compared
| Product | Manufacturer | Status | Substitution |
|---|---|---|---|
| Lantus | Sanofi | Available (vial); SoloStar pen intermittent | Brand — Copay Card / Valyou apply |
| Semglee | Biocon/Viatris | Discontinued 12/31/2025 | No longer an option |
| Rezvoglar | Eli Lilly | Available | Interchangeable — pharmacist can typically substitute |
| Basaglar | Eli Lilly | Available | Not interchangeable — needs new prescription |
| Generic insulin glargine | Multiple | Available, regional variability | Cash-pay alternative |
| Toujeo | Sanofi | Available | Different concentration (U-300) — not unit-for-unit |
If your prescriber is considering a switch to a Novo Nordisk basal insulin like Tresiba instead of another glargine product, that manufacturer runs its own $35/month program through NovoCare, separate from anything Sanofi offers. Our manufacturer savings card guides cover the Lilly-run programs for Basaglar and Rezvoglar in more detail, including the Lilly Insulin Value Program's own $35 structure through Lilly Cares.
11. How to Enroll Step-by-Step
Identify your insurance status
Commercial insurance points you to the Copay Savings Card. Uninsured or cash-pay points you to the Valyou Savings Program. Neither works with Medicare or Medicaid.
Register at lantus.com
Sign up for the correct program before your pharmacy visit. Registration takes only a few minutes and confirms your eligibility upfront.
If you take multiple Sanofi insulins, plan your fills together
Under Valyou, fill all your Sanofi insulin prescriptions on the same visit each month to make sure the combined $35 cap applies correctly.
Present your card at the pharmacy
Hand over your registered card along with your prescription. Most major pharmacy chains and many independents are familiar with both Sanofi programs.
If cost is still a barrier, apply to Sanofi Patient Connection
Have your prescriber help complete the application if your income falls at or below 400% of the Federal Poverty Level and you lack coverage.
12. Approval Timelines
| Program | Typical Timeline |
|---|---|
| Copay Savings Card | Immediate once registered |
| Insulins Valyou Savings Program | Immediate once registered |
| Sanofi Patient Connection | Typically 2–4 weeks with a complete application |
| Prior authorization, if your plan requires it | Usually 3–14 business days, longer if appealed |
If your Lantus prescription is stuck in a coverage review, our prior authorization guide covers documentation that typically speeds up approval.
13. Renewal Process
Sanofi periodically republishes the terms of both the Copay Savings Card and the Valyou Savings Program. Set a reminder near the start of each year to confirm your registration is still active and the $35 figure hasn't changed. If your pharmacy suddenly quotes a higher price, that's usually the first sign a renewal or re-registration is needed. Sanofi Patient Connection enrollees should expect a periodic income and coverage recheck as well.
14. Decision Path: Which Program Fits You?
Separate question either way: if you can't find your usual Lantus product in stock, that's a supply issue, not a savings issue — see the Semglee update above and our shortage guide for what to ask your pharmacist about switching to Rezvoglar or generic glargine.
15. Real Patient Examples
| Patient | Situation | Best Path | Result |
|---|---|---|---|
| Angela, 58 | Employer insurance, high-deductible plan | Copay Savings Card | $35/fill, well under her deductible copay |
| Tomas, 41 | Recently uninsured after a job change | Insulins Valyou Program | $35/month instead of ~$300 cash price |
| Renee, 66 | Fixed income, no insurance, below 400% FPL | Sanofi Patient Connection | Free Lantus after a ~3-week approval |
16. Pros and Cons
Pros
- No income requirement for either the Copay Card or Valyou Program
- Works for both insured and uninsured patients at the same $35 target price
- Free option available through Sanofi Patient Connection for very low income
- Instant activation for both main programs — no waiting period
Cons
- Two separate programs with different rules is genuinely confusing
- Excludes Medicare and Medicaid entirely
- Valyou's combined cap requires filling all Sanofi insulins together
- SoloStar pen supply has been intermittent since Semglee's discontinuation